Use of a predictive protocol to measure the antimicrobial resistance risks associated with biocidal product usage  by Wesgate, Rebecca et al.
Major article
Use of a predictive protocol to measure the antimicrobial resistance
risks associated with biocidal product usage
Rebecca Wesgate BSc a, Pierre Grasha PhD b, Jean-Yves Maillard BSc, PhD a,*
a Cardiff School of Pharmacy and Pharmaceutical Sciences, Cardiff University, Cardiff, UK
b Deb Group, Denby, UK
Key Words:
Resistance
antibiotics
biocides
predictive protocol
Background: In this study we assessed the propensity of biocide exposure in the development of anti-
microbial resistance in bacteria.
Methods: Our protocol is based on reporting changes in established antimicrobial susceptibility pro-
ﬁles in biocides and antibiotics after during use exposure to a product. The during use exposure reﬂects
worse conditions of product use during application. It differs from the term low concentration, which
usually reﬂects a concentration below the minimal inhibitory concentration, but not necessarily a con-
centration that occurs in practice.
Results: Our results showed that exposure to triclosan (0.0004%) was associated with a high risk of de-
veloping resistance and cross-resistance in Staphylococcus aureus and Escherichia coli. This was not observed
with exposure to chlorhexidine (0.00005%) or a hydrogen peroxide–based biocidal product (in during use
conditions). Interestingly, exposure to a low concentration of hydrogen peroxide (0.001%) carried a risk
of emerging resistance to antibiotics if the presence of the oxidizing agent was maintained. We ob-
served a number of unstable clinical resistances to antibiotics after exposure to the cationic biocide and
oxidizing agent, notably to tobramycin and ticarcillin–clavulanic acid.
Conclusions: Using a decision tree based on the change in antimicrobial susceptibility test results, we
were able to provide information on the effect of biocide exposure on the development of bacterial re-
sistance to antimicrobials. Such information should address the call from the U.S. Food and Drug
Administration and European Union Biocidal Products Regulation for manufacturers to provide informa-
tion on antimicrobial resistance and cross-resistance in bacteria after the use of their product.
© 2016 Association for Professionals in Infection Control and Epidemiology, Inc. Published by Elsevier
Inc. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/
licenses/by-nc-nd/4.0/).
In January 2013, the U.S. Food and Drug Administration
proposed a rule to determine the safety and effectiveness of
antibacterial soap (http://www.fda.gov/newsevents/newsroom/
pressannouncements/ucm378542.htm), whereby manufacturers of
antibacterial hand soaps and body washes need to demonstrate that
their products are safe for long-term daily use. This rule is based
on the concern that long-term exposure to certain active ingredi-
ents, such as triclosan (TRI), may be associated with bacterial
resistance and therefore pose a health risk.1,2 This proposed rule
echoes the European Biocidal Product regulation (effective from Sep-
tember 1, 2013; articles 19-b/ii, 37, and 47-1/b), which asks
manufacturers to provide information on the antimicrobial resis-
tance associated with their biocidal products.3 This follows a number
of European reports on the association of biocides with antimicro-
bial resistance.4,5 Because of the increased use of biocidal products
worldwide for a mounting number of applications, particularly do-
miciliary ones (eg, washing up liquid, surfaces, stationary, textiles),
it is not surprising that biocidal products used at a low concentra-
tion, for example after dilution, or released in the environment at
low concentrations, produce a selective pressure for bacteria to
express resistance mechanisms.1,2,4,6-9 In 2010, the European Scien-
tiﬁc Committee on Emerging and Newly Identiﬁed Health Risks
reported on the dearth of information concerning biocide expo-
sure on the development of antimicrobial resistance in bacteria5 and
in particular the need for a standard protocol that could measure
the ability of a biocide to induce or select for antimicrobial resis-
tance in bacteria. Recently, a protocol reﬂective of the in use
conditions of biocides was proposed.7 Knapp et al reported on the
use of this protocol to determine the effect of exposure to
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chlorhexidine, benzalkonium chloride, and 3 biocidal products to
Pseudomonas aeruginosa, Burkholderia cepacia, B lata, Klebsiella
pneumoniae, and 2 Salmonella enterica serovar Typhimurium
strains.10,11
Bacterial resistance to cationic agents (eg, biguanides, quater-
nary ammonium compounds) and phenolics (eg, TRI) has been
widely reported2,4,6,7,9,11-14 and is often perceived to present a higher
risk for the development of bacterial resistance to antimicrobials.
A number of resistance mechanisms to these biocides have been
described, including overexpression of eﬄux and changes in bac-
terial surface.7,15 Bacterial resistance to highly reactive biocides such
as alkylating and oxidizing agents has also been reported.6,16,17 An
outbreak of Mycobacterium massiliense in particular showed for the
ﬁrst time a clinical isolate, with resistance to glutaraldehyde and
all the frontline antimycobacterial antimicrobials, causing signiﬁ-
cant public concern.17
In this study we explored the use of a predictive protocol7 to de-
termine changes in the antimicrobial susceptibility proﬁle of
Staphylococcus aureus and Escherichia coli when exposed to TRI,
chlorhexidine gluconate solution (CHG), hydrogen peroxide, and a
hydrogen peroxide–based product.
MATERIALS AND METHODS
Bacterial strains, growth conditions, and storage of cultures
One representative gram-positive and 1 gram-negative bacte-
ria were selected for testing against 1 formulated biocidal product
and 3 biocides. The bacterial strains chosen were S aureus (NCIMB
9518) and E coli (NCIMB 8545).18,19 Both bacteria are commonly used
in standard eﬃcacy test protocols. Liquid cultures of all strains were
grown in tryptone soya broth (TSB) (Oxoid, Basingstoke, UK) at 37°C
± 1°C for 16-24 hours. Strains were stored on protect beads (Fisher
Scientiﬁc, Loughborough, UK) at −80°C ± 1°C and restricted to a
maximum of 2 subcultures from the original freezer stock prior to
exposure to a given biocide. Test inocula were prepared from har-
vesting an overnight TSB culture centrifuged at 5,000 g for 10minutes
and resuspended in deionized water (diH20).
Formulations, actives, and neutralizer
A hydrogen peroxide–based foaming lotion for hand disinfec-
tion (Oxy BAC F31 RO 1331; DEB Group, Denby, UK) was tested at
1% and 0.001% H2O2 (ﬁnal concentration). Three unformulated bio-
cides, TRI (0.0004% in 5% dimethyl sulfoxide [DMSO]), CHG
(0.00005%), and hydrogen peroxide (0.001%), were also used. All bio-
cides were neutralized with 5 g/L sodium thiosulfate. Neutralizer
toxicity and eﬃcacy to quench the biocides were tested as de-
scribed by Knapp et al10 and conﬁrmed (data not shown).
Antimicrobial susceptibility testing
The protocol to evaluate the effect of biocide exposure on the
susceptibility proﬁle and stability of bacterial isolates has been
described.7,11 Brieﬂy, it consists of 3 parts: (1) an initial back-
ground antimicrobial susceptibility proﬁle of test bacteria before
biocide exposure, (2) exposure of test bacteria to during use con-
centration of test biocide or biocidal products, and (3) determination
of antimicrobial susceptibility proﬁle of biocide-exposed bacteria
and stability proﬁle of any change in antimicrobial susceptibility.
During use exposure reﬂects the worst-case scenario during product
usage by customers, notably dilution of product and lengthy contact
time. It differs from the term low concentration, which usually re-
ﬂects a concentration below the minimal inhibitory concentration
(MIC), but not necessarily a concentration that occurs in practice.
The manufacturer guidelines for during use exposure conditions of
the biocidal product were used.
Suspension testing and exposure to microbicide
Bacterial exposure to biocides and biocidal products was carried
out in suspension using the British Standards Institute suspension
test protocol.18 Brieﬂy, bacterial suspensions in diH20 produced from
overnight cultures were standardized to 1 × 108 colony forming
units/mL through optical density measurement. Suspensions were
used within 15 minutes of preparation. One milliliter of standard-
ized suspension was added to 9mL of the appropriate concentration
of a biocide-product (diluted in diH20) at 1.25 times the required
concentration for a 30-second, 5-minute, and 24-hour exposure. Then
1 mL of this suspension was removed and added to 9 mL of neu-
tralizer. After neutralization, suspensions were centrifuged at 5,000 g
for 10 minutes, and the supernatant was discarded. The remain-
ing cells were then used in further antimicrobial susceptibility testing
experiments. Concentrations of biocide tested were as follows: Oxy
BAC F31 RO 1331 1% and 0.001%, unformulated H2O2 0.001%, TRI
0.0004%, and CHG 0.00005%. The 1% concentration of the formu-
lated product corresponded to the during use concentration, whereas
the lower concentrations for the oxidizing agents and the cationic
biocides corresponded to a concentration that resulted in a 1 log10
reduction in colony forming units per milliliter, leaving suﬃcient
survivors for further antimicrobial susceptibility testing.
MIC and minimal bactericidal concentration
TheMIC of each biocide was determined before and after biocide
exposure with the British Standards Institute protocol.19 To deter-
mine the minimal bactericidal concentration (MBC), 20 μL of
suspension was removed from each well of the MIC microtiter plate
where no bacterial growth was observed and the 2 lowest biocide
concentrations at which growth was observed, and they were plated
onto a tryptone soy agar plate containing 10% neutralizer. After
24 hours of incubation at 37°C, the MBC was deﬁned as the lowest
biocide concentration where no bacterial growth was observed.11
Antibiotic susceptibility testing
The susceptibility of both bacteria to the following antibiotics
was determined before and after biocide exposure using the Euro-
pean Committee on Antimicrobial Susceptibility Testing disk diffusion
protocol:20 ampicillin (10 μg), ciproﬂoxacin (1 μg), ceftazidime
(30 μg), tobramycin (10 μg), ticarcillin–clavulanic acid (75:10 μg),
and gentamicin (10 μg). These antibiotics were selected because of
their use as therapeutic agents in the treatment of infections with
the organisms chosen for this study.
Phenotype stability testing
The stability of observed changes in antimicrobial susceptibil-
ity proﬁle was investigated by 24 hours subculturing of surviving
bacteria in TSB with or without a biocide; the exposure concen-
trations previously described were used.11 Changes in the
antimicrobial susceptibility proﬁle were measured using the pro-
tocol previously described following 1, 5, and 10 subcultures. A check
of culture purity was performed at each stage.
Reproducibility
Tests were carried out in triplicate on 3 separate occasions. No
statistical analysis was conducted on antibiotic breakpoints because
only the clinical resistance breakpoint given by European Commit-
tee on Antimicrobial Susceptibility Testing20 was of interest. Likewise,
no statistical analysis was performed on the MIC-MBC data. Here
a signiﬁcant change in the susceptibility proﬁle corresponding to
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a >15-fold difference was used as a breakpoint. Further justiﬁca-
tion is given in the text.
RESULTS
One oxidizing formulation and 3 biocides were evaluated against
2 commonly used bacteria in standard eﬃcacy test protocols. TRI
was used as a positive control because, according to the literature,
a change in the antimicrobial susceptibility proﬁle could be ex-
pected using the bisphenol.2,4 The mean MIC and MBC for each
bacteria before and after exposure to TRI (0.0004%) and CHG
(0.00005%), unformulated H2O2 (0.001%), and Oxy BAC (0.001% and
1%) are presented in Tables 1 and 2. To ease the interpretation of
the results, the fold change in susceptibility is presented in Tables 1
and 2. This corresponds to the difference in susceptibility (MIC or
MBC) before and after exposure to the biocides. Exposure of S aureus
to TRI (0.0004%) resulted in signiﬁcant increases in antimicrobial
insusceptibility, particularly after 5 minutes of contact with, for
example, a 69- and 74-fold increase in both MIC and MBC, respec-
tively. Such an increase in MIC and MBC was not observed with S
aureus exposure to TRI for 24 hours. A signiﬁcant increase in MIC
only (>30-fold change) was observed after E coli exposure to the
bisphenol. Exposure of either bacteria to CHG (0.00005%), H2O2
(0.001%), and Oxy BAC (0.001%) did not result in changes in the sus-
ceptibility proﬁle (<2-fold change) (Tables 1 and 2). A 30-second
exposure of both bacteria to Oxy BAC (1%) did not result in changes
in the susceptibility proﬁle, and exposure beyond 30 seconds re-
sulted in no viable bacteria recovered (Table 2). To determine
whether or not observed changes in the biocide susceptibility proﬁle
were stable, 24-hour exposed bacteria were propagated in 24-
hour subculture in the presence or not of biocide and biocidal
products and retested for their antimicrobial susceptibility proﬁle
after 1, 5, and 10 subcultures (Table 3). E coli exposed to TRI (0.0004%)
and passage with or without the bisphenol retained a high MIC for
10 passages. The propagation of E coli in TRI resulted in a 163-fold
increase in MIC after the ﬁrst passage and then in a 32- and 16-
fold increase in MIC after the 5th and 10th passages, respectively.
There was no change in the S aureus susceptibility proﬁle, except
for an unstable increase in MBC after the ﬁrst passage with or
without TRI (Table 3). The other biocides did not alter the antimi-
crobial susceptibility proﬁle of both bacteria, and passaging them
in the presence or not of biocides did not result in any changes either;
however, S aureus exposed to Oxy BAC (0.001%) presented a 16-fold
increase in MIC after the 10th passage. The differences in results
in passaging in biocide-free broth (Table 3) resulted from the fact
that the bacteria that were passaged were isolated from the dif-
ferent biocides in the ﬁrst place. As such, the results from the biocide-
free broth are not directly comparable.
A clinical change in antibiotic susceptibility proﬁle was ob-
served after bacterial exposure to the biocide and biocidal product,
and such change in susceptibility was stable after some biocide ex-
posure (Table 4). A 30-second and 5-minute exposure of S aureus
to TRI (0.0004%) induced clinical resistance to ciproﬂoxacin, but a
24-hour exposure to the bisphenol did not alter the antibiotic sus-
ceptibility proﬁle. Passaging bacteria exposed to TRI (0.0004%) for
24 hours resulted in a stable resistance to ampicillin whether the
subculturing was performed in the presence of TRI or not. A 24-
hour exposure to CHG (0.00005%) resulted in E coli exhibiting an
unstable clinical resistance to tobramycin. Other clinical resis-
tance to antibiotics was observed in E coli, but these were not stable
(Table 4). Of particular interest was the observation of S aureus stable
clinical resistance to ciproﬂoxacin, particularly in the presence of
H2O2 (0.001%). A 24-hour exposure of E coli in H2O2 (0.001%) also
resulted in an unstable resistance to ampicillin. Exposure to the for-
mulated product at 0.001% resulted in stable resistance to ampicillin
in E coli after 5 subcultures in the presence of the formulation
(Table 4).
A larger number of results were produced after the execution
of our protocols, and the practical signiﬁcance and implication of
the results needs to be considered. By creating a decision tree re-
ﬂecting every step of the protocol in terms of change in susceptibility
proﬁle, a clearer understanding of the interpretation of the results
can be obtained (Fig 1). Every step is followed by a yes or no ques-
tion and leads to a clear observation of the risk resulting from the
biocide and biocidal product exposure. Here, for all results com-
bined, exposure to CHG (0.00005%) and Oxy BAC (1%) resulted in
no signiﬁcant change in antimicrobial biocide susceptibility proﬁle
and no stable change in antibiotic susceptibility proﬁle. This expo-
sure to these biocide and biocidal products at the concentration
tested is deemed not to present a risk for emerging bacterial re-
sistance (Fig 1). On the other hand, exposure to TRI (0.0004%) resulted
in stable antimicrobial susceptibility changes to both antibiotics and
biocides; with that in mind, exposure to TRI at this concentration
is associated with a signiﬁcant risk in bacteria developing resis-
tance and cross-resistance (Fig 1). Exposure to H2O2 (0.001%) resulted
in a change in the antibiotic susceptibility proﬁle after passaging
Table 1
Mean MIC and MBC for both bacteria before and after exposure to triclosan (0.0004%) or chlorhexidine (0.00005%)
Pre-exposure Exposure: 30 s Exposure: 5 min Exposure: 24 h
MIC, % MBC, % MIC, % MBC, % MIC, % MBC, % MIC, % MBC, %
Triclosan (0.0004%)
Staphylococcus aureus 0.0009
± 0.0000
0.0017
± 0.0000
0.0047
± 0.0027
0.1250
± 0.000
0.0625
± 0.0000
0.1250
± 0.000
0.0079
± 0.0000
0.0031
± 0.0000
Fold change in susceptibility 5 74 69 74 9 2
Escherichia coli 0.0002
± 0.0000
0.0017
± 0.0000
0.0065
± 0.0023
0.0065
± 0.0023
0.0078
± 0.0000
0.0078
± 0.0000
0.0063
± 0.0000
0.0063
± 0.0000
Fold change in susceptibility 33 4 39 4 32 4
Chlorhexidine (0.00005%)
S aureus 0.0004
± 0.0000
0.0078
± 0.0003
0.0009
± 0.0027
0.0156
± 0.0000
0.0006
± 0.0003
0.0020
± 0.0000
0.0020
± 0.0000
0.0020
± 0.0000
Fold change in susceptibility 2 2 <2 −4 5 −4
E coli 0.0007
± 0.0003
0.0078
± 0.0000
0.0006
± 0.0003
0.0026
± 0.0000
0.0039
± 0.0034
0.0052
± 0.0022
0.0026
± 0.0011
0.0039
± 0.0000
Fold change in susceptibility 0 −3 6 <−2 4 −2
NOTE. Values are mean ± SD or as otherwise indicated. A negative value denotes an increase in susceptibility.
Abbreviations: MBC, minimal bactericidal concentration; MIC, minimal inhibitory concentration.
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in the presence of the biocide. Hence the risk associated with ex-
posure to H2O2 (0.001%) is associated with the permanent exposure
to this oxidizing agent at that concentration (Fig 1). The use of this
decision tree (Fig 1) based on the susceptibility proﬁle results pro-
vides the information necessary for manufacturers to make a case
for the safety of their products in terms of development and se-
lection for antimicrobial resistance. It also provides the regulators
with an easy tool to assess the risk imparted to bacteria after bio-
cidal product exposure.
DISCUSSION
The objective of this work was to make use of a predictive
protocol7 to determine the effect of bacterial exposure to TRI, CHG,
H2O2, and OxyBAC F31 RO 1331, which active is H2O2. The protocol
used is designed to expose bacteria to product under during use con-
ditions, which reﬂect the worse-case scenario of product usage (eg,
dilution, prolonged exposure during application). This was the case
for Oxy BAC, which was tested at a concentration of 1% for
30 seconds. Because of the bactericidal activity of Oxy BAC, it was
also decided to test lower concentrations and longer contact time,
which did not reﬂect product usage in practice but would allow bac-
terial survival and exposure to long contact time. Likewise, with TRI,
CHG, and H2O2, the concentrations tested allowed enough bacte-
rial survival (data not shown) after exposure so that a change in the
antimicrobial susceptibility proﬁle could be measured after addi-
tional testing.
Evaluation of biocidal products, rather than just active ingredi-
ents, is important to consider because the formulation will impact
on the overall eﬃcacy of the product, but this has often been
Table 2
Mean MIC and MBC for both bacteria before and after exposure to hydrogen peroxide (0.001%) or Oxy BAC (0.001% and 1%)
Pre-exposure Exposure: 30 s Exposure: 5 min Exposure: 24 h
MIC, % MBC, % MIC, % MBC, % MIC, % MBC, % MIC, % MBC, %
Hydrogen peroxide (0.001%)
Staphylococcus aureus 0.160
± 0.000
0.160
± 0.000
0.042
± 0.000
0.083
± 0.000
0.042
± 0.000
0.083
± 0.000
>0.300
± 0.000
>0.300
±0.000
Fold change in susceptibility −4 −2 −4 −4 >2 >2
Escherichia coli 0.083
± 0.000
0.083
± 0.000
0.042
± 0.000
0.042
± 0.000
0.042
± 0.000
0.042
± 0.000
0.132
± 0.049
0.160
± 0.000
Fold change in susceptibility −2 −2 −2 −2 2 2
Oxy BAC (0.001%)
S aureus 0.0026
± 0.0000
0.0052
± 0.0000
0.0026
± 0.0000
0.0052
± 0.0000
0.0026
± 0.0000
0.0026
± 0.0000
0.0026
± 0.0000
0.014
± 0.0000
Fold change in susceptibility 0 0 0 −2 0 3
E coli 0.0104
± 0.0000
0.0104
± 0.0000
0.0104
± 0.0000
0.0104
± 0.0000
0.0052
± 0.0000
0.0104
± 0.0000
0.0208
± 0.0000
0.0208
± 0.0000
Fold change in susceptibility 0 0 −2 0 −2 2
Oxy BAC (1%)
S aureus 0.0052
± 0.0000
0.0052
± 0.0000
0.0026
± 0.0000
0.0026
± 0.0000
— — NT NT
Fold change in susceptibility −2 −2
E coli 0.0416
± 0.0000
0.0416
± 0.0000
0.1040
± 0.0000
0.1040
± 0.0000
— — NT NT
Fold change in susceptibility 2.5 2.5
NOTE. Values are mean ± SD or as otherwise indicated. A negative value denotes an increase in susceptibility.
Abbreviations: MBC, minimal bactericidal concentration; MIC, minimal inhibitory concentration; NT, not tested; —, no survivor.
Table 3
Fold changes in MIC and MBC (compared with baseline data) after 1, 5, and 10 passages in biocide- and biocidal-free product or biocide and biocidal product
Folds change in MIC and MBC
At 24 h
Passage
1 5 10
MIC MBC MIC MBC MIC MBC MIC MBC
Triclosan-free Staphylococcus aureus 9 2 9 37 2 2 3 2
Escherichia coli 32 4 39 37 16 2 16 2
Triclosan (0.0004%) S aureus 9 2 9 18 2 2 2 4
E coli 32 4 163 9 32 2 16 4
CHX-free S aureus 5 −4 5 −4 5 −2 5 −2
E coli 4 −2 3 −4 3 −4 3 −2
CHX (0.00005%) S aureus 5 −4 5 −4 5 −2 5 −4
E coli 4 −2 3 −2 3 −2 3 −2
H2O2-free S aureus >2 >2 >2 >2 >2 >2 >2 >2
E coli 2 2 2 2 2 2 2 2
H2O2 (0.001%) S aureus >2 >2 >2 >2 >2 >2 >2 >2
E coli 2 2 2 4 4 4 2 4
Oxy BAC–free S aureus 0 3 2 4 2 4 16 8
E coli 2 2 0 8 0 8 4 8
Oxy BAC (0.001%) S aureus 0 3 2 4 2 4 16 8
E coli 2 2 0 4 2 4 8 8
Abbreviations: MBC, minimal bactericidal concentration; MIC, minimal inhibitory concentration.
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overlooked.7 Knapp et al evaluated the effect of the exposure to 3
biocidal products at their during use concentrations and found a
signiﬁcant increase in MBC; however, the concentrations attained
were still below or equal to the concentration of active in these prod-
ucts during use.11 Kurenbach et al reported a decreased antimicrobial
susceptibility of E coli and S enterica Typhimurium after exposure
to 3 commercially available herbicides.21 This contrasts with the study
from Condell et al, who did not observe any correlation between
reduced susceptibility to 8 food industry biocide formulations and
resistance to clinically relevant antimicrobial compounds in a panel
of 189 Salmonella isolates. The use of unformulated TRI,
chlorhexidine, and benzalkonium chloride was associated with an
increased tolerance to antimicrobials.22
TRI and CHG were chosen because both biocides have been im-
plicated in a change in antimicrobial susceptibility proﬁle, notably
a documented rise in MIC and MBC associated or not with a change
in antibiotic susceptibility proﬁle. TRI in particular has been shown
to produce increased antimicrobial insusceptibility in a wide range
Table 4
Changes in antibiotic susceptibility proﬁle after exposure to biocide and biocidal product and 1, 5, and 10 passaging in biocide- and biocidal-free product or biocide and
biocidal product
Exposure Passage with biocide Passage without biocide
30 s 5 min 24 h 1 5 10 1 5 10
Triclosan (0.0004%) Staphylococcus aureus CIP CIP — — AMP AMP AMP AMP AMP
Escherichia coli — — — AMP AMP AMP AMP — —
CHG (0.0004%) S aureus — — — — — — — — —
E coli — — TOB TIM — AMP TIM — —
H2O2 (0.001%) S aureus — — CIP CIP, AMP CIP CIP CIP — —
E coli — — AMP — — — — — —
Oxy BAC 0.001% S aureus — — — — — — TIM — —
E coli — — — — AMP AMP — — —
NOTE. Where the antibiotic is named, the bacterium became clinically resistant to that antibiotic according to European Committee on Antimicrobial Susceptibility Testing
breakpoints.20
Abbreviations: AMP, ampicillin; CHG, chlorhexidine gluconate; CIP, ciproﬂoxacin; TIM, ticarcillin–clavulanic acid; TOB, tobramycin; —, no change in susceptibility.
Fig 1. Bacterial resistance to biocides: decision tree.
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of bacteria.23-28 In some studies, TRI insusceptibility correlates with
multiple drug resistance13,29; however, a recent report minimized
the impact of TRI exposure on the development of antibiotic resis-
tance in S aureus.30 Furthermore, it has been observed that bacterial-
resistant subpopulations to TRI, benzalkonium chloride, and
chlorhexidine in clinical isolates may be uncommon.31 Several
mechanisms have been implicated in bacterial resistance to
biocides.7,15,32,33 Eﬄux has been implicated in producing resistance
to both TRI and antibiotics,34 including ampicillin13,22 and
ciproﬂoxacin.35,36 Our study was essentially an observational one,
and at this stage we did not investigate the mechanisms of resis-
tance implicated in the change of susceptibility proﬁles to
antimicrobials.
In our study, short and long exposure to TRI (0.0004%) elicited
a signiﬁcant and stable increase in MIC in E coli, but it did not elicit
a clinical change in antibiotic susceptibly. Prolonged exposure (sub-
culturing) in the presence of TRI however produced a stable clinical
resistance change in ampicillin. A prolonged treatment to TRI has
been associated with stable changes in antimicrobial susceptibili-
ty proﬁles in S enterica serovar Typhimurium.13 Here, the response
of S aureus to TRI was somewhat different from that of E coli, with
a signiﬁcant increase in MBC after short contact time with TRI to-
gether with a clinical resistance to ciproﬂoxacin. Subculturing S
aureus in the presence of TRI or not resulted in stable ampicillin re-
sistance. Shorter S aureus exposure to TRI yielded larger changes
in MIC-MBC. Although we do not have a direct mechanistic expla-
nation for these observations, we can speculate that cumulative
damage may have occurred. TRI is a phenolic compound and will
affect the bacterial membrane somewhat. Longer exposure in TRI
may cause suﬃcient membrane damage to the bacteria, negating
any bacterial adaptation. Cumulative damage could also explain the
lack of stability in antimicrobial tolerance observed by Knapp et al
after S enterica Typhimuriumwas exposed to chlorhexidine and ben-
zalkonium chloride.11 Exposure of both S aureus and E coli to TRI
presented a risk for the development of resistance in both bacte-
ria. These results conﬁrm conclusions from other studies13,22,32 and
establish the use of TRI as an acceptable positive control.
Bacterial resistance to CHG has been reported in
staphylococci.14,26,27,30,37 Here we did not observe a change in the
chlorhexidine susceptibility proﬁle after short and long exposures
to the biguanide. Subculturing bacteria in CHG containing broth did
not alter the antimicrobial susceptibility proﬁle. Some changes in
antibiotic susceptibility proﬁle were observed in E coli after 24-
hour exposure to chlorhexidine (0.00005%), but these changes were
not stable. Changes in the antibiotic susceptibility proﬁle after
chlorhexidine (>0.0002%) exposure have been reported in P stutzeri38
and S enterica.12 A recent study observed a positive moderate cor-
relation between CHG and antibiotic resistance in S aureus.30
We also investigated exposure to a low concentration of H2O2
(0.001%). Although the bacterial susceptibility proﬁle to H2O2 did
not change after short or long (24 h) exposure to (Table 2), or re-
peated subculturing in (Table 3), the oxidizing agent, a stable change
in ciproﬂoxacin resistance was observed when S aureus was sub-
cultured in the presence of H2O2. This clinical resistance to
ciproﬂoxacin was unstable without H2O2 selective pressure (Table 3).
It is conceivable that prolonged exposure to H2O2 induced the ex-
pression of the SoxRS system, which itself regulates the expression
of eﬄux pumps among a number of defense mechanisms.39 The in-
duction of the OxyR regulon after H2O2 exposure could also lead to
the production of scavengers, notably the regulation of katG
catalase.39 The level of expression of calatase genes, such as katG,
was not investigated here. As a contrast, only an unstable clinical
resistant to ampicillin was observed in E coli exposed to H2O2 for
24 hours. Wang et al40 found that several regulatory genes respon-
sive to oxidative stress and antibiotic resistance (marRAB, among
others) were upregulated after E coli exposure to H2O2. Such a bac-
terial response was not observed when S aureuswas exposed to the
biocidal product (Table 3). Instead, clinical resistance to ampicillin
was observed in E coli after the ﬁfth subculturing in the presence
to Oxy BAC (0.001%). Other clinical resistance to antibiotics was re-
ported, but these were not stable; notably, these were resistance
to tobramycin in E coli after 24-hour exposure to CHG (0.00005%)
and ticarcillin–clavulanic acid after subculturing E coli and S aureus
to CHG (0.00005%) and Oxy BAC (0.001%), respectively (Table 3). From
the literature it is likely that the mechanisms eliciting cross-
resistance are multifactorial.32,33,41 It is interesting to note that many
of the clinical resistances to antibiotics were not stable. Without a
better understanding of the mechanisms involved, it is diﬃcult to
ascertain whether these unstable changes are caused by eﬄux ex-
pression driven by the selective pressure or detrimental mutations
that only confer an advantage in the presence of the biocide. Except
for the clinical resistance to ampicillin in S aureus as a result of TRI
exposure, all other clinical resistances to antibiotics were lost after
>1 subculturing in biocide-free media (Table 3).
This study looked at combining standard eﬃcacy protocols to
determine the propensity of biocide and biocidal products to cause
antimicrobial resistance in bacteria. StandardMIC-MBCmicrodilution
broth test protocols19 combined with standard antibiotic suscepti-
bility testing20 were used to ensure result reproducibility. Although
our study was not repeated over time, Knapp et al11 reported on
experimental reproducibility of antimicrobial susceptibility testing
using these protocols, where experiments were performed over a
6-month period. A small variation in MIC-MBC was observed, but
this was deemed not to be practically signiﬁcant because the use
of microdilution broth means that a change in just one dilution will
impinge negatively on the SD, especially when high concentra-
tions are concerned.11
We have brought forward the concept of during use concentra-
tion, which reﬂects the worst-case scenario of concentration and
contact time for a biocidal product during application. This also ac-
knowledges that a biocidal product may be diluted during use or
remain present for an extended length of time. This is quite differ-
ent from the in use concentration of a biocide reported on packaging,
which is the concentration that is used tomake a product claim after
for example British Standards Institute and Food and Drug Admin-
istration standard eﬃcacy testing. By acknowledging the actual
conditions of use of a biocidal product (ie, any dilution resulting
from use, prolonged contact time), this test provides a realistic as-
sessment of the selective pressure exerted by the product on
application. It is informative to note that high MICs to cationic bio-
cides, but not to TRI, have been positively correlated with the
prediction of multidrug resistance in staphylococci.37
Our study made a number of interesting observations, notably
where a stable clinical resistance to antibiotics was measured. Un-
fortunately, the aim was not to investigate the mechanisms of
resistance involved at this stage, and such observations warrant ad-
ditional studies.5,7 Instead we presented a decision tree to help
manufacturers understand the risks associated with their prod-
ucts (Fig 1). The use of such a decision tree should favorably address
the request from the U.S. Food and Drug Administration and Euro-
pean Union Biocidal Products Regulations (http://www.fda.gov/
newsevents/newsroom/pressannouncements/ucm378542.htm)3 for
manufacturers to provide information on antimicrobial resistance
and cross-resistance in bacteria after the use of their products.
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